List of Heidelberg Pharma patents

List of Heidelberg Pharma patents

List of MorphoSys patents

List of Oncolytics Biotech patents

List of Scancell patents

List of companies in SportMaster Sport Surfaces's investment portfolio

List of funding rounds for Fishbrain

Patents where

Current Assignee

Name

is

Heidelberg Pharma

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11446388 Amanitin antibody conjugates	Patent 11446388 was granted and assigned to Heidelberg Pharma on September, 2022 by the United States Patent and Trademark Office.	Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	11446388	September 20, 2022
	‌ US Patent 11420971 Method for synthesizing amanitins	Patent 11420971 was granted and assigned to Heidelberg Pharma on August, 2022 by the United States Patent and Trademark Office.	Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	11420971	August 23, 2022
	‌ US Patent 11590238 Amanitin conjugates		Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	11590238	February 28, 2023
	‌ US Patent 9676702 Methods for synthesizing amatoxin building block and amatoxins	Patent 9676702 was granted and assigned to Heidelberg Pharma on June, 2017 by the United States Patent and Trademark Office.	Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	9676702	June 13, 2017
	‌ US Patent 11583569 PSMA-targeting amanitin conjugates	Patent 11583569 was granted and assigned to Heidelberg Pharma on February, 2023 by the United States Patent and Trademark Office.	Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	11583569	February 21, 2023
	‌ US Patent 10961277 Method for synthesizing amanitins	Patent 10961277 was granted and assigned to Heidelberg Pharma on March, 2021 by the United States Patent and Trademark Office.	Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	10961277	March 30, 2021
	‌ US Patent 9982018 Amatoxin derivatives	Patent 9982018 was granted and assigned to Heidelberg Pharma on May, 2018 by the United States Patent and Trademark Office.	Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	9982018	May 29, 2018
	‌ US Patent 9630907 Methods for synthesizing amatoxin building block and amatoxins	Patent 9630907 was granted and assigned to Heidelberg Pharma on April, 2017 by the United States Patent and Trademark Office.	Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	9630907	April 25, 2017
	‌ US Patent 10842882 Amatoxin-antibody conjugates	Patent 10842882 was granted and assigned to Heidelberg Pharma on November, 2020 by the United States Patent and Trademark Office.	Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	10842882	November 24, 2020
	‌ US Patent 10723766 Derivatives of gamma-amanitin		Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	10723766	July 28, 2020
	‌ US Patent 7378401 Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases	Patent 7378401 was granted and assigned to Heidelberg Pharma on May, 2008 by the United States Patent and Trademark Office.		Heidelberg Pharma		United States Patent and Trademark Office	7378401	May 27, 2008
	‌ US Patent 11584708 Synthesis of (2S,3R,4R)-4,5-dihydroxyisoleucine and derivatives		Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	11584708	February 21, 2023
	‌ US Patent 11702451 Method for synthesizing amanitins		Heidelberg Pharma	Heidelberg Pharma		United States Patent and Trademark Office	11702451	July 18, 2023

13 results

0 selected

13 results

0 selected